News

Insightful Overview of Cellectis' Share Capital Dynamics

Insightful Overview of Cellectis' Share Capital Dynamics

Exploring Cellectis' Share Capital and Voting Rights

Cellectis is always striving to keep its investors informed about critical metrics related to its share capital. Understanding these numbers not only reflects the company’s financial health but also signifies how shareholders can influence company decisions.

Current Share Capital Status

The latest figures reveal a robust structure, showcasing a total of 100,325,229 shares. This figure reflects the company’s commitment to transparency and engagement with its shareholders.

Voting Rights Overview

In conjunction with the total number of shares, there are 89,428,630 voting rights associated with these shares. Voting rights are an important aspect for investors as they provide a mechanism to influence company decisions, from electing board members to approving significant corporate changes.

Cellectis' Commitment to Shareholders

For Cellectis, maintaining an informed shareholder base is crucial. The communication of share capital data is part of a larger strategy to build trust and transparency with stakeholders.

Media and Investor Relations

Investors and media contacts play a significant role in how information is disseminated. For those interested in more details, Cellectis encourages communication through various channels. Pascalyne Wilson, the Director of Communications, can be reached for media inquiries, while Arthur Stril serves as the Chief Financial Officer and is available for investor relations.

The Importance of Regular Updates

Regular updates on share capital are vital in today’s fast-paced market environment. Cellectis has established a strong framework to ensure that investors receive timely information, allowing for strategic decision-making.

Future Expectations

Looking ahead, stakeholders can expect continued updates as Cellectis moves forward with its initiatives. The focus on growth and innovation remains a driving force as Cellectis seeks to expand its market presence.

Frequently Asked Questions

What is the total number of shares for Cellectis?

As of the latest update, there are 100,325,229 shares in the capital of Cellectis.

How many voting rights are associated with these shares?

There are currently 89,428,630 voting rights linked to the shares of Cellectis.

Who can I contact for further information about Cellectis?

Media inquiries can be directed to Pascalyne Wilson, while investor relations inquiries should reach out to Arthur Stril.

Why are voting rights important?

Voting rights allow shareholders to influence decisions regarding the company’s governance and major business strategies.

How often are updates provided about share capital?

Cellectis aims to provide regular updates to keep its shareholders well-informed about any changes in share capital and voting rights.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 87

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 84

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 170

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
Rock Tech Uncovers Major Lithium Discovery at Victory

Updated Category News Views 84

Rock Tech's Game-Changer at Victory Folks, we've got a shake-up in the lithium landscape over in Ontario, courtesy of Rock Tech Lithium Inc. They just unearthed something quite promising at their Victory Project: a spanking new spodumene-bearing pegmatite discovery. Now I know, if you're like me, you're thinking, 'What's the angle here?' Well, this isn't just another hole...

Continue Reading
TCL Unveils Black Friday Steals on Smart Devices

Updated Category News Views 128

TCL's Big Move This Holiday Season When was the last time you saw a deal that actually made you stop and check your wallet? Well, TCL is giving you a reason to dig deep this Black Friday and Cyber Monday. They're slashing prices across smartphones and tablets, trying to elbow their way into your shopping cart with discounts up to $150. Now that's the kind of aggressive...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 146

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 98

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 64

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 96

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
equipifi's BNPL Shop: New Ammo for Credit Unions

Updated Category News Views 94

equipifi's 'Shop': The Big Play in Banking Look, here’s the deal—equipifi just lobbed a new grenade into the finance battlefield, arming credit unions and community banks with 'Shop', their own Buy Now, Pay Later (BNPL) platform. The goal? To put them toe-to-toe with the big fintech wolves—something these smaller guys desperately needed. It's a meaty move, no...

Continue Reading